Increased Risk of Dementia in Patients with Chronic Obstructive Pulmonary Disease

Medicine (United States)

Volumn 94, Issue 23, 2015, Pages e930-

  Liao, Kuang Ming ^a,b   Ho, Chung Han ^a,c   Ko, Shian Chin ^a   Li, Chung Yi ^d,e  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEAD INJURY; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ICD-9-CM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX DIFFERENCE; COMPLICATION; MIDDLE AGED;

AGED; ALZHEIMER DISEASE; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84940028568     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000930     Document Type: Article

References (23)

1. Pauwels RA, Buist AS, Calverley PM, et al., GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001;163:1256-1276.
2. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J. 2010;35:913-922.
3. Grant I, Heaton RK, McSweeny AJ, et al. Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med. 1982;142:1470-1476.
4. Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. N Engl J Med. 2003;348:1356-1364.
5. Greig NH, Mattson MP, Perry T, et al. New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNFalpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci. 2004;1035:290-315.
6. Li CH, Chen WC, Liao WC, et al. The association between chronic obstructive pulmonary disease and Parkinson's disease: a nationwide population-based retrospective cohort study. QJM. 2015;108:39-45.
7. Chi NF, Chien L-N, Ku H-L, et al. Alzheimer disease and risk of stroke: a population-based cohort study. Neurology. 2013;80:705-717.
8. Rusanen M, Ngandu T, Laatikainen T, et al. Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study. Curr Alzheimer Res. 2013;10:549-555.
9. Singh B, Mielke MM, Parsaik AK, et al. A prospective study of chronic obstructive pulmonary disease and the risk for mild cognitive impairment. JAMA Neurol. 2014;71:581-588.
10. Bednarek M, Maciejewski J, Wozniak M, et al. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax. 2008;63:402-407.
11. Prieto Centurion V, Huang F, Naureckas ET, et al. Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012;12:73-80.
12. Hnizdo E, Glindmeyer HW, Petsonk EL, et al. Case definitions for chronic obstructive pulmonary disease. COPD. 2006;3:95-100.
13. Jafari S, Etminan M, Aminzadeh F, et al. Head injury and risk of Parkinson disease: a systematic review and meta-analysis. Mov Disord. 2013;28:1222-1229.
14. Sivanandam TM, Thakur MK. Traumatic brain injury: a risk factor for Alzheimer's disease. Neurosci Biobehav Rev. 2012;36:1376-1381.
15. Tajiri N, Kellogg SL, Shimizu T, et al. Traumatic brain injury precipitates cognitive impairment and extracellular Ab aggregation in Alzheimer's disease transgenic mice. PLoS One. 2013;8:e78851.
16. Johnson VE, Stewart W, Smith DH. Traumatic brain injury and amyloid-b pathology: a link to Alzheimer's disease? Nat Rev Neurosci. 2010;11:361-370.
17. Schernhammer E, Hansen J, Rugbjerg K, et al. Diabetes and the risk of developing Parkinson's disease in Denmark. Diabetes Care. 2011;34:1102-1108.
18. Arvanitakis Z, Wilson RS, Bienias JL, et al. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004;61:661-666.
19. Akomolafe A, Beiser A, Meigs JB, et al. Diabetes mellitus and risk of developing Alzheimer disease: results from the Framingham Study. Arch Neurol. 2006;63:1551-1555.
20. Roberts RO, Geda YE, Knopman DS, et al. Association of Creactive protein with mild cognitive impairment. Alzheimers Dement. 2009;5:398-405.
21. Roberts RO, Geda YE, Knopman DS, et al. Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study. Alzheimer Dis Assoc Disord. 2010;24:11-18.
22. Wysocki M, Luo X, Schmeidler J, et al. Hypertension is associated with cognitive decline in elderly people at high risk for dementia. Am J Geriatr Psychiatry. 2012;20:179-187.
23. de la Torre JC. Critical threshold cerebral hypoperfusion causes Alzheimer's disease? Acta Neuropathol. 1999;98:1-8.